Rioux Patrice has filed 6 Form 4s with the SEC that we hold, all for Monopar Therapeutics (MNPR), as Reporting owner. Across all of them we count 0 purchases worth $0 and 1 sale worth $111 reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($111). The largest single trade was a sale of 1 shares of Monopar Therapeutics worth $111, dated 2026-08-26. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-01-04 and the latest 2026-08-27.
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-08-26 | S, sale reported on Form 4 | 1 | $111 | 2026-08-27 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1241033) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms
No password to create and no card required. We store your email address and nothing else.